AM-132 gene therapy (Zenyth Therapeutics)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAM-132 gene therapy (Zenyth Therapeutics)
Drug Alias NameVEGF-B gene therapy (AMRAD)VEGF-B gene therapy (Zenyth Therapeutics)AM-132 gene therapy (AMRAD)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionVascular endothelial growth factor B stimulants
TargetsVascular endothelial growth factor B
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenAustralia and New Zealand +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCSL Innovation PTY Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCollateral Therapeutics, IncCSL Innovation PTY LtdCentelion SAS +[5] 
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A